Epigenetics in Hematological Malignancies

Methods Mol Biol. 2018:1856:87-101. doi: 10.1007/978-1-4939-8751-1_5.

Abstract

Acute leukemias are hematologic malignancies with aggressive behavior especially in adult population. With the introduction of new gene expression and sequencing technologies there have been advances in the knowledge of the genetic landscape of acute leukemias. A more detailed analysis allows for the identification of additional alterations in epigenetic regulators that have a profound impact in cellular biology without changes in DNA sequence. These epigenetic alterations disturb the physiological balance between gene activation and gene repression and contribute to aberrant gene expression, contributing significantly to the leukemic pathogenesis and maintenance. We review epigenetic changes in acute leukemia in relation to what is known about their mechanism of action, their prognostic role and their potential use as therapeutic targets, with important implications for precision medicine.

Keywords: Acute leukemia; Epigenetics; Hematopoiesis; Regulation.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Biomarkers, Tumor
  • Cell Transformation, Neoplastic / genetics
  • DNA Methylation
  • Epigenesis, Genetic*
  • Epigenomics / methods
  • Gene Expression Regulation, Neoplastic*
  • Genetic Association Studies
  • Genetic Predisposition to Disease*
  • Hematologic Neoplasms / diagnosis
  • Hematologic Neoplasms / genetics*
  • Hematologic Neoplasms / metabolism
  • Hematologic Neoplasms / therapy
  • Histones / metabolism
  • Humans
  • Models, Biological
  • Molecular Targeted Therapy
  • Mutation
  • Protein Processing, Post-Translational
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Histones